Providing the Perfect Prescription for Eli Lilly

The Challenge

The global pharmaceutical company Eli Lilly planned to discontinue six international operations through translocation of systems into one operation in the U.S. and one in Spain. Strategic planning and process specifications were needed to construct and operate these two new world-class pharmaceutical-manufacturing facilities – and both budget and timeline were critical.

The Solution

Norman Partners team members developed a strategy to drive the project and align it with future business growth. We created consensus within the organization around team design, innovation plans, processes, organizational structure, systems and tools. We provided leadership to the executive committee to ensure the success of all planning, design, contractor selection, logistics, owner's representation and start-up efforts.

The Result

Both operations were successfully completed 12½ weeks ahead of schedule at a cost of $31 million (which was $4 million under the "impossible" budget of $35 million). ISO Certification and FDA approval were achieved far ahead of the customer’s anticipated schedule.

Norman Partners team members provided:

  • +Real Estate & Facilities Strategy
  • +Relocation Strategy
  • +Business Strategy Mapping
  • +Core Business Process Mapping
  • +Project Delivery Mapping
  • +Capital Planning & Restructuring
  • +work Place Planning & Flow
  • +Feasibility Studies & Analysis
  • +Strategic Needs Analysis
  • +Project Management
  • +Development Management
  • +Change Management
  • +Facilities Operations Planning

Long Term Prognosis for Virginia Mason Medical Center

The Challenge

Virginia Mason Medical Center (VM) has been in their current location since it was formed in 1920. They expanded their campus over the years and as the area around them developed, land has become more expensive and rare. Given their plans to construct a new hospital on the site, in addition to reshuffling some uses within their existing space, the VM Executives and the Board were concerned about the cost of refitting older buildings, the constraints of building a new hospital wing and tying it into existing facilities, and the cost of long term growth.

The Solution

The senior management of Virginia Mason Medical Center retained members of the Norman Partners team to provide a high-level strategic analysis of the potential benefits and deficiencies of VM's continuation at their then current First Hill Campus in Seattle. We examined and analyzed the following key issues in order to provide a meaningful and supportable strategy: VM's general business strategy, value of current campus, order of magnitude costs of "stay" vs. "go", associated issues and benefits, funding options and balance sheet impacts.

The Result

Our team analyzed all the key issues and presented our findings to the Executive Team and the Finance Committee of the Board of Directors of Virginia Mason Medical Center. The report provided management with a full understanding of their options and ultimately they made the decision to expand their campus on First Hill near downtown Seattle.

Norman Partners team members provided:

  • +Real Estate & Facilities Strategy
  • +Relocation Strategy
  • +Capital Planning
  • +Feasibility Studies & Analysis
  • +Strategic Needs Analysis
  • +Change Management
  • +Facilities Operations Planning